221 related articles for article (PubMed ID: 31772034)
21. Visualizing structural transitions of ligand-dependent gating of the TRPM2 channel.
Yin Y; Wu M; Hsu AL; Borschel WF; Borgnia MJ; Lander GC; Lee SY
Nat Commun; 2019 Aug; 10(1):3740. PubMed ID: 31431622
[TBL] [Abstract][Full Text] [Related]
22. 8-Br-cADPR, a TRPM2 ion channel antagonist, inhibits renal ischemia-reperfusion injury.
Eraslan E; Tanyeli A; Polat E; Polat E
J Cell Physiol; 2019 Apr; 234(4):4572-4581. PubMed ID: 30191993
[TBL] [Abstract][Full Text] [Related]
23. A critical role of the transient receptor potential melastatin 2 channel in a positive feedback mechanism for reactive oxygen species-induced delayed cell death.
Li X; Jiang LH
J Cell Physiol; 2019 Apr; 234(4):3647-3660. PubMed ID: 30229906
[TBL] [Abstract][Full Text] [Related]
24. Lys1110 of TRPM2 is critical for channel activation.
Kim TK; Nam JH; Ahn WG; Kim NH; Ham HY; Hong CW; Nam JS; Lee J; Huh SO; So I; Kim SJ; Song DK
Biochem J; 2013 Nov; 455(3):319-27. PubMed ID: 23957292
[TBL] [Abstract][Full Text] [Related]
25. Functional Restoration following Global Cerebral Ischemia in Juvenile Mice following Inhibition of Transient Receptor Potential M2 (TRPM2) Ion Channels.
Dietz RM; Orfila JE; Chalmers N; Minjarez C; Vigil J; Deng G; Quillinan N; Herson PS
Neural Plast; 2021; 2021():8774663. PubMed ID: 34659399
[TBL] [Abstract][Full Text] [Related]
26. Conserved cysteine residues in the pore region are obligatory for human TRPM2 channel function.
Mei ZZ; Mao HJ; Jiang LH
Am J Physiol Cell Physiol; 2006 Nov; 291(5):C1022-8. PubMed ID: 16822940
[TBL] [Abstract][Full Text] [Related]
27. Loss of glutathione homeostasis associated with neuronal senescence facilitates TRPM2 channel activation in cultured hippocampal pyramidal neurons.
Belrose JC; Xie YF; Gierszewski LJ; MacDonald JF; Jackson MF
Mol Brain; 2012 Apr; 5():11. PubMed ID: 22487454
[TBL] [Abstract][Full Text] [Related]
28. Scalaradial Is a Potent Inhibitor of Transient Receptor Potential Melastatin 2 (TRPM2) Ion Channels.
Starkus JG; Poerzgen P; Layugan K; Kawabata KG; Goto JI; Suzuki S; Myers G; Kelly M; Penner R; Fleig A; Horgen FD
J Nat Prod; 2017 Oct; 80(10):2741-2750. PubMed ID: 29019677
[TBL] [Abstract][Full Text] [Related]
29. Flufenamic acid is a pH-dependent antagonist of TRPM2 channels.
Hill K; Benham CD; McNulty S; Randall AD
Neuropharmacology; 2004 Sep; 47(3):450-60. PubMed ID: 15275834
[TBL] [Abstract][Full Text] [Related]
30. Reversal of Global Ischemia-Induced Cognitive Dysfunction by Delayed Inhibition of TRPM2 Ion Channels.
Dietz RM; Cruz-Torres I; Orfila JE; Patsos OP; Shimizu K; Chalmers N; Deng G; Tiemeier E; Quillinan N; Herson PS
Transl Stroke Res; 2020 Apr; 11(2):254-266. PubMed ID: 31250378
[TBL] [Abstract][Full Text] [Related]
31. Effects of calcium-binding sites in the S2-S3 loop on human and Nematostella vectensis TRPM2 channel gating processes.
Luo YH; Yu XF; Ma C; Yang F; Yang W
J Zhejiang Univ Sci B; 2019 Dec.; 20(12):972-982. PubMed ID: 31749344
[TBL] [Abstract][Full Text] [Related]
32. Ligand recognition and gating mechanism through three ligand-binding sites of human TRPM2 channel.
Huang Y; Roth B; Lü W; Du J
Elife; 2019 Sep; 8():. PubMed ID: 31513012
[TBL] [Abstract][Full Text] [Related]
33. New molecular mechanisms on the activation of TRPM2 channels by oxidative stress and ADP-ribose.
Naziroğlu M
Neurochem Res; 2007 Nov; 32(11):1990-2001. PubMed ID: 17562166
[TBL] [Abstract][Full Text] [Related]
34. Methods for Investigating Transient Receptor Potential Melastatin-2 (TRPM2): A Cation Channel Activated by ADP-Ribose and Involved in Cell Death.
Hall HK; Koh DW
Methods Mol Biol; 2023; 2609():213-226. PubMed ID: 36515838
[TBL] [Abstract][Full Text] [Related]
35. Identification of the ADPR binding pocket in the NUDT9 homology domain of TRPM2.
Yu P; Xue X; Zhang J; Hu X; Wu Y; Jiang LH; Jin H; Luo J; Zhang L; Liu Z; Yang W
J Gen Physiol; 2017 Feb; 149(2):219-235. PubMed ID: 28108595
[TBL] [Abstract][Full Text] [Related]
36. TRPM2: a calcium influx pathway regulated by oxidative stress and the novel second messenger ADP-ribose.
Kühn FJ; Heiner I; Lückhoff A
Pflugers Arch; 2005 Oct; 451(1):212-9. PubMed ID: 15952035
[TBL] [Abstract][Full Text] [Related]
37. TRPM2: a candidate therapeutic target for treating neurological diseases.
Belrose JC; Jackson MF
Acta Pharmacol Sin; 2018 May; 39(5):722-732. PubMed ID: 29671419
[TBL] [Abstract][Full Text] [Related]
38. Medicinal chemistry perspective of TRPM2 channel inhibitors: where we are and where we might be heading?
Zhang H; Zhao S; Yu J; Yang W; Liu Z; Zhang L
Drug Discov Today; 2020 Dec; 25(12):2326-2334. PubMed ID: 33065292
[TBL] [Abstract][Full Text] [Related]
39. Synthesis of Terminal Ribose Analogues of Adenosine 5'-Diphosphate Ribose as Probes for the Transient Receptor Potential Cation Channel TRPM2.
Baszczyňski O; Watt JM; Rozewitz MD; Guse AH; Fliegert R; Potter BVL
J Org Chem; 2019 May; 84(10):6143-6157. PubMed ID: 30978018
[TBL] [Abstract][Full Text] [Related]
40. Structural and functional basis of the selectivity filter as a gate in human TRPM2 channel.
Yu X; Xie Y; Zhang X; Ma C; Liu L; Zhen W; Xu L; Zhang J; Liang Y; Zhao L; Gao X; Yu P; Luo J; Jiang LH; Nie Y; Yang F; Guo J; Yang W
Cell Rep; 2021 Nov; 37(7):110025. PubMed ID: 34788616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
